Evidence map›Paper›PMID 26719361›Full record

ArticleAmerican journal of physiology. Renal physiology2016

Aquaporin 11 variant associates with kidney disease in type 2 diabetic patients.

David P Choma, Roberto Vanacore, Helen Naylor, Ian A Zimmerman, Andrei Pavlichenko, Artyom Pavlichenko, Liberty Foye, David P Carbone, Raymond C Harris, Mikhail M Dikov and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. The Vanderbilt O'Brien Kidney Center.American journal of physiology. Renal physiology · 2021
    Review
  12. Article
  13. Aquaporins in Renal Diseases.International journal of molecular sciences · 2019
    Review
  14. Indirect Proton MR Imaging and Kinetic Analysis ofMagnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

David P ChomaDivision of Nephrology and Hypertension, Vanderbilt University, Nashville, Tennessee;
Roberto VanacoreDivision of Nephrology and Hypertension, Vanderbilt University, Nashville, Tennessee;
Helen NaylorKnowledge Management/Research Informatics Consult Service, Vanderbilt University, Nashville, Tennessee;
Ian A ZimmermanKentucky College of Osteopathic Medicine, University of Pikeville, Pikeville, Kentucky;
Andrei PavlichenkoMathematics Department, University of Missouri, Columbia, Missouri;
Artyom PavlichenkoUniversity of Illinois, Champaign, Illinois; and.
Liberty FoyeDivision of Nephrology and Hypertension, Vanderbilt University, Nashville, Tennessee;
David P CarboneDepartment of Internal Medicine, The Ohio State University Medical Center, Columbus, Ohio.
Raymond C HarrisDivision of Nephrology and Hypertension, Vanderbilt University, Nashville, Tennessee;
Mikhail M DikovDepartment of Internal Medicine, The Ohio State University Medical Center, Columbus, Ohio.
Elena E TcheknevaDepartment of Internal Medicine, The Ohio State University Medical Center, Columbus, Ohio elena.tchekneva@osumc.edu.
Vanderbilt University · USThe Ohio State University Wexner Medical Center · USThe Ohio State University · USUniversity of Illinois Urbana-Champaign · USUniversity of Missouri · USUniversity of Pikeville · US

Funding

VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
The Role of the EGF Receptor in Acute and Chronic Renal InjuryR01DK051265 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RAYMOND C. HARRIS, Mingzhi Zhang · 1997 to 2026
$10.1M
The role of the innate immune cell cyclooxygenase/prostaglandin system in blood pressureregulationR01DK062794 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RAYMOND C. HARRIS, Mingzhi Zhang · 2003 to 2026
$9.4M
The Role of renal macrophages in recovery from renal injuryR01DK095785 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RAYMOND C. HARRIS, Mingzhi Zhang · 2013 to 2026
$6.7M
Novel Integrated Analyses of Human Diabetic NephropathyR24DK103067 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CAPRIOLI, RICHARD M, DENNY, JOSHUA C. · 2014 to 2018
$6.5M
The role of lysyl oxidase like-2 in chronic kidney diseaseR01DK099467 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI VANACORE, ROBERTO MARCELO · 2013 to 2023
$3.8M
NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1-TR-000445NCRR NIH HHS 1-UL1-RR-024975-01NCRR NIH HHS UL1 RR024975NIDDK NIH HHS DK-51265NIDDK NIH HHS DK-62794NIDDK NIH HHS DK-95785NIDDK NIH HHS R01 DK051265NIDDK NIH HHS R01 DK062794NIDDK NIH HHS R01 DK095785NIDDK NIH HHS R01 DK099467NIDDK NIH HHS R24 DK103067
6 · The paper itself

Abstract

Kidney disease, a common complication of diabetes, associates with poor prognosis. Our previous animal model studies linked aquaporin (AQP)11 to acute kidney injury, hyperglycemia-induced renal impairment, and kidney disease in diabetes. Here, we report the AQP11 rs2276415 variant as a genetic factor placing type 2 diabetic patients at greater risk for the development of kidney disease. We performed two independent retrospective case-control studies in 1,075 diabetic and 1,619 nondiabetic individuals who were identified in the Synthetic Derivative Database with DNA samples in the BioVU DNA repository at Vanderbilt University (Nashville, TN). A χ(2)-test and multivariable logistic regression analysis with adjustments for age, sex, baseline serum creatinine, and underlying comorbid disease covariates showed a significant association between rs2276415 and the prevalence of any event of acute kidney injury and chronic kidney disease (CKD) in diabetic patients but not in patients without diabetes. This result was replicated in the second independent study. Diabetic CKD patients over 55 yrs old with the minor AQP11 allele had a significantly faster progression of estimated glomerular filtration rate decline than patients with the wild-type genotype. Three-dimensional structural analysis suggested a functional impairment of AQP11 with rs2276415, which could place diabetic patients at a higher risk for kidney disease. These studies identified rs2276415 as a candidate genetic factor predisposing patients with type 2 diabetes to CKD.

Indexed as

Polymorphism, Single NucleotideAcute Kidney InjuryAgedAquaporinsChi-Square DistributionDatabases, GeneticDiabetes Mellitus, Type 2Diabetic NephropathiesDisease ProgressionFemaleGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseGlomerular Filtration RateHumansLinear ModelsAQP11 protein, humanAquaporinsacute kidney injurychronic kidney injurydiabetes mellitusproximal tubules

Identifiers

PMID26719361
PMCPMC4773830
OpenAlexW2289980247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.